ArticleInternational journal of oncology2019

The HSP90 inhibitor onalespib potentiates 177Lu‑DOTATATE therapy in neuroendocrine tumor cells.

Sara Lundsten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.